BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21804386)

  • 1. Role of TP53 mutations in vulvar carcinomas.
    Choschzick M; Hantaredja W; Tennstedt P; Gieseking F; Wölber L; Simon R
    Int J Gynecol Pathol; 2011 Sep; 30(5):497-504. PubMed ID: 21804386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
    Kashofer K; Regauer S
    Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of epithelial disorders adjacent to invasive vulvar carcinomas.
    Rouzier R; Morice P; Haie-Meder C; Lhomme C; Avril MF; Duvillard P; Castaigne D
    Gynecol Oncol; 2001 Jun; 81(3):414-9. PubMed ID: 11371131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV-negative vulvar intraepithelial neoplasia (VIN) with basaloid histologic pattern: an unrecognized variant of simplex (differentiated) VIN.
    Ordi J; Alejo M; Fusté V; Lloveras B; Del Pino M; Alonso I; Torné A
    Am J Surg Pathol; 2009 Nov; 33(11):1659-65. PubMed ID: 19730361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostication of vulvar cancer based on p14ARF status: molecular assessment of transcript and protein.
    Lavorato-Rocha AM; de Melo Maia B; Rodrigues IS; Stiepcich MM; Baiocchi G; da Silva Cestari FM; Carvalho KC; Soares FA; Rocha RM
    Ann Surg Oncol; 2013 Jan; 20(1):31-9. PubMed ID: 22878614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of wild-type p53 in lichen sclerosus adjacent to human papillomavirus-negative vulvar cancer.
    Vanin K; Scurry J; Thorne H; Yuen K; Ramsay RG
    J Invest Dermatol; 2002 Nov; 119(5):1027-33. PubMed ID: 12445188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 mutations and clonality in vulvar carcinomas and squamous hyperplasias: evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papillomavirus-negative vulvar carcinomas.
    Kim YT; Thomas NF; Kessis TD; Wilkinson EJ; Hedrick L; Cho KR
    Hum Pathol; 1996 Apr; 27(4):389-95. PubMed ID: 8617483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas.
    Santos M; Landolfi S; Olivella A; Lloveras B; Klaustermeier J; Suárez H; Alòs L; Puig-Tintoré LM; Campo E; Ordi J
    Am J Surg Pathol; 2006 Nov; 30(11):1347-56. PubMed ID: 17063073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus (HPV) profiles of vulvar lesions: possible implications for the classification of vulvar squamous cell carcinoma precursors and for the efficacy of prophylactic HPV vaccination.
    Skapa P; Zamecnik J; Hamsikova E; Salakova M; Smahelova J; Jandova K; Robova H; Rob L; Tachezy R
    Am J Surg Pathol; 2007 Dec; 31(12):1834-43. PubMed ID: 18043037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned.
    van de Nieuwenhof HP; van Kempen LC; de Hullu JA; Bekkers RL; Bulten J; Melchers WJ; Massuger LF
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2061-7. PubMed ID: 19567503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased survival in EGFR gene amplified vulvar carcinoma.
    Growdon WB; Boisvert SL; Akhavanfard S; Oliva E; Dias-Santagata DC; Kojiro S; Horowitz NS; Iafrate AJ; Borger DR; Rueda BR
    Gynecol Oncol; 2008 Nov; 111(2):289-97. PubMed ID: 18768215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome.
    Tessier-Cloutier B; Pors J; Thompson E; Ho J; Prentice L; McConechy M; Aguirre-Hernandez R; Miller R; Leung S; Proctor L; McAlpine JN; Huntsman DG; Gilks CB; Hoang LN
    Mod Pathol; 2021 Feb; 34(2):508-518. PubMed ID: 32792599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma.
    Del Pino M; Rodriguez-Carunchio L; Ordi J
    Histopathology; 2013 Jan; 62(1):161-75. PubMed ID: 23190170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and epigenetic changes in vulvar squamous cell carcinoma and its precursor lesions: a review of the current literature.
    Trietsch MD; Nooij LS; Gaarenstroom KN; van Poelgeest MI
    Gynecol Oncol; 2015 Jan; 136(1):143-57. PubMed ID: 25448458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic changes during the multistage pathogenesis of human papillomavirus positive and negative vulvar carcinomas.
    Flowers LC; Wistuba II; Scurry J; Muller CY; Ashfaq R; Miller DS; Minna JD; Gazdar AF
    J Soc Gynecol Investig; 1999; 6(4):213-21. PubMed ID: 10486784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gains of chromosome region 3q26 in intraepithelial neoplasia and invasive squamous cell carcinoma of the vulva are frequent and independent of HPV status.
    Aulmann S; Schleibaum J; Penzel R; Schirmacher P; Gebauer G; Sinn HP
    J Clin Pathol; 2008 Sep; 61(9):1034-7. PubMed ID: 18559375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The absence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to the HPV-independent pathway as the causative agent for vulvar squamous cell carcinoma and its precursor simplex VIN in a young patient.
    Kruse AJ; Bottenberg MJ; Tosserams J; Slangen B; van Marion AM; van Trappen PO
    Int J Gynecol Pathol; 2008 Oct; 27(4):591-5. PubMed ID: 18753959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus infection in squamous cell carcinoma of the vulva, in various synchronous epithelial changes and in normal vulvar skin.
    Kagie MJ; Kenter GG; Zomerdijk-Nooijen Y; Hermans J; Schuuring E; Timmers PJ; Trimbos JB; Fleuren GJ
    Gynecol Oncol; 1997 Nov; 67(2):178-83. PubMed ID: 9367704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases.
    Al-Ghamdi A; Freedman D; Miller D; Poh C; Rosin M; Zhang L; Gilks CB
    Gynecol Oncol; 2002 Jan; 84(1):94-101. PubMed ID: 11748983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
    Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
    Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.